Progressive Vision Institute Of Bethlehem Pc | |
2151 Fairview Ave, Easton, PA 18042-3858 | |
(610) 258-4334 | |
(610) 258-9418 |
Full Name | Progressive Vision Institute Of Bethlehem Pc |
---|---|
Type | Facility |
Speciality | Ophthalmology |
Location | 2151 Fairview Ave, Easton, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1629521935 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | (* (Not Available)) | Secondary |
207W00000X | Ophthalmology | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Progressive Vision Institute Of Bethlehem Pc 201 E Laurel Blvd, Pottsville, PA 17901-2534 Ph: (570) 628-4444 | Progressive Vision Institute Of Bethlehem Pc 2151 Fairview Ave, Easton, PA 18042-3858 Ph: (610) 258-4334 |
News Archive
Immune Network, a company in the business of development and commercialization of immune therapies, announced today that its newly acquired business, Immunitor, has published interim data from the ongoing Phase IIb imm01 clinical trial of V5 in tuberculosis conducted at its second site in Ukraine.
While initial studies suggest a potential relationship between air pollution and both infertility and menstrual irregularity, researchers from Boston University School of Medicine believe more studies are needed to validate these findings in other populations.
Even though few people suffer burns in Sweden, about 16 per 10,000 inhabitants, burn treatment occupies a unique position in health care. First, a major burn is one of the worst injuries a person can suffer and still survive.
Athera Biotechnologies AB, an atherosclerosis R&D company developing novel products for treatment and prevention of cardiovascular disease (CVD), announced today that the European Patent Office intends to grant two key patents related to the Company's intellectual property on its two pharmaceutical candidates Annexin A5 and PC-mAb.
Warring armies use a variety of tactics as they struggle to gain the upper hand. Among their tricks is to attack with a decoy force that occupies the defenders while an unseen force launches a separate attack that the defenders fail to notice.
› Verified 3 days ago